Chinook Therapeutics Inc (NASDAQ:KDNY)

24.80
Delayed Data
As of 3:59pm ET
 -1.12 / -4.32%
Today’s Change
11.16
Today|||52-Week Range
27.44
-5.34%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Samsara Biocapital Llc
Director
Buy5/27/2022570,000$14.00$8.0M+68.09%
Dobmeier Eric L
President & Chief Executive Officer
Sale12/01/202230,000$22.31$669.3K+15.30%
King Andrew /chinook/
Chief Scientific Officer
Sale1/03/202310,000$25.82$258.2K+1.89%
Frohlich Tom /versant Ventures/
Chief Operating Officer
Sale12/13/202210,000$25.00$250.0K+3.56%
Frohlich Tom /versant Ventures/
Chief Operating Officer
Sale11/07/202210,000$22.16$221.6K+14.89%
Thomas Dolca
Director
Buy9/02/20229,700$21.22$205.8K+22.15%
Frohlich Tom /versant Ventures/
Chief Operating Officer
Sale10/06/20227,360$19.69$144.9K+30.38%
Bjerkholt Eric Hands Claude
Chief Financial Officer
Sale12/01/20225,770$22.29$128.6K+15.30%
King Andrew /chinook/
Chief Scientific Officer
Sale8/04/20225,000$20.00$100.0K+27.25%
King Andrew /chinook/
Chief Scientific Officer
Sale7/11/20225,000$18.09$90.5K+44.48%
Page of 4